Description
Curated Content for EPs: Pulsed Field AblationThis bundle includes 5 sessions and 3.75 ACE credits.Sessions from HRS2023 included in this bundle:
- 454568 - What's New in Pulsed Field Ablation
- 452672 - Pulsed Field Ablation: Insights from Preclinical Studies
- 436412 - Puled Field/Irreversible Electroporation: What's New?
The following episodes of The Beat and The Lead are also included:
- The Beat Webinar Series - Episode 3: Pulsed Field Ablation - A Shift in Technology?
- The Lead Podcast Episode 10: A Discussion of Pulsed Field Ablation for the Treatment of Atrial Fibrillation - PULSED AF Pivotal Trial
- The Lead Podcast Episode 48: Influence of monitoring and atrial arrhythmia burden on quality of life and health care utilization in patients undergoing pulsed field ablation
Learning Objectives
- Summarize the basics of pulsed-field ablation
- Interpret new clinical findings of pulsed-field ablation
- Compare the characteristics of lesions using the different ablation technologies (RF, Cryo, and PF)
Target Audience
This activity is designed for Physicians, Advanced Practice Providers, and other Allied Professionals in the Field of EP.
Faculty and Faculty Disclosures
Amim Al-Ahmad, MD, FHRS, CCDS
Honoraria, Speaking/Consulting Fee: Medtronic, Boston Scientific, Abbott Medical, BioSense Webster, Inc., MediaSphere Medical, Medtelligence, BioSig Technologies, Toray, Haemonetics, Philips, E-safe, Shifamed, SoundCathEquity in E-safe, SoundCath, Encompass Vascular, Myra Vision, Supira Medical, Tioga Cardiovascular, Akura MedicalThomas Dewland:Honoraria/Speaking/Consulting Fee: Adagio Medical Luigi Di Biase:Honoraria/Speaking/Consulting Fee: Baylis Medical Company (Honoraria/Speaking/Consulting Fee), Biosense Webster, Inc., Abbott, Boston Scientific, Medtronic, Biotronik, Rhythm Management Group Corp, Zoll Medical Corporation Edward Gerstenfeld:Honoraria/Speaking/Consulting Fee: Medtronic, Boston Scientific, Biosense Webster, Inc., Abbott, Thermedical Melanie Gunawardene, MD
Honoraria, Speaking/Consulting Fee: Farapulse, Abbott MedicalFellowship Support: Boston ScientificTravel: Biosense Webster, Inc.Satoshi Higuchi
Nothing Relevant to Disclose Philippa Hill
Nothing Relevant to Disclose Ayman HusseinResearch (Contracted Grants for PIs and Named Investigators only): Boston Scientific
Atsushi Ikeda
Nothing Relevant to Disclose
Michael S. Lloyd, MD, FHRS
Honoraria, Speaking/Consulting Fee: Medtronic, Boston Scientific, Abbott Medical, Balis Medical CompanySanghamitra Mohanty
Nothing Relevant to Disclose Jacopo Marazzato
Nothing Relevant to Disclose Hiroshi Nakagawa:Honoraria/Speaking/Consulting Fee:Biosense Webster, Inc., Affera, Inc., Fukuda-Denshi, Japan Lifeline, Stereotaxis, Inc, Acutus Medical Inc, Galaxy Medical, IncShady Nakhla
Nothing Relevant to Disclose Andrea Natale, MD, FHRSHonoraria, Speaking/Consulting Fee: Medtronic, Boston Scientific, Abbott Medical, BioSense Webster Inc., Baylis Medical Company, BiotronikJonathan Piccini:Research Contracted Grants for PIs and Named Investigators only: Boston Scientific , Bayer Healthcare Pharmaceuticals, Abbott, Philips, Element Science, Inc, iRhythm Technologies,Honoraria/Speaking/Consulting Fee: Abbott, Medtronic, Philips, LivaNova, Sanofi, Biotronik, AbbVie, ARCA Biopharma Inc. Bristol-Myers Squibb Boston Scientific ElectroPhysiology Frontiers, Itamar Medical, UpToDate, Inc.,Walid Saliba:Honoraria/Speaking/Consulting Fee: Boston Scientific, AtriCure, Inc., Cardiva Medical, Inc.
Javier Sanchez, MDNothing to disclose.Prashanthan Sanders, MBBS, PhD, FHRS
Honoraria, Speaking/Consulting Fee: Medtronic, Boston Scientific, Abbott MedicalResearch: Medtronic, Boston Scientific, Abbott Medical CathRx, Pacemate, MicroPort Scientific Corporation, Becton Dickinson, EBR SystemsPasquale Santangeli
Honoraria/Speaking/Consulting Fee: Abbott, Biosense Webster, Inc., Medtronic, Asahi MedicalResearch (Contracted Grants for PIs and Named Investigators only): Biosense Webster, Inc.
William H. Sauer, MD, FHRS, CCDS
Honoraria/Speaking/Consulting: Biotronik, Biosense Webster, Inc., Abbott, Boston Scientific
Research: Medtronic
Oussama Wazni:
Honoraria/Speaking/Consulting Fee: Boston Scientific, Biosense Webster, Inc.
Boris Schmidt, MD, FHRS
Honoraria, Speaking/Consulting Fee: Medtronic, Boston Scientific, Abbot, Bionsense Webster Inc., CardioFocus Inc.
Research: Farapulse
Nathaniel Steiger, MD
Nothing to disclose.
Masafumi Sugawara
Nothing Relevant to Disclose
Kamala Tamirisa, MD, FHRS
Honoraria, Speaking/Consulting Fee: Medscape, Abbott Medical
Paul C Zei, MD, PhD, FHRS
Honoraria/Speaking/Consulting: Varian Medical Systems, Biosense Webster, Inc., Abbott
Research: Biosense Webster, Inc.
Stocks, Publicly Traded: Affera, Inc.
Fengwei Zou
Nothing Relevant to Disclose
Disclosure Policy
Disclosure Policy
The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.
Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.
ACCME Definition:
*An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Examples of such organizations include:
- Advertising, marketing, or communication firms whose clients are ineligible companies
- Bio-medical startups that have begun a governmental regulatory approval process
- Compounding pharmacies that manufacture proprietary compounds
- Device manufacturers or distributors
- Diagnostic labs that sell proprietary products
- Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
- Manufacturers of health-related wearable products
- Pharmaceutical companies or distributors
- Pharmacy benefit managers
- Reagent manufacturers or sellers
All relevant financial relationships have been mitigated.
ACE Statements
Accreditation Statement
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians AMA Designation Statement
The Heart Rhythm Society designates this internet-enduring activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM Maintenance of Certification (MOC) Statement

Successful completion of this ACE activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of ACE credits claimed for the activity. It is the ACE activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Royal College of Physicians and Surgeons of Canada MOC Recognition Statement
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “ACE in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Other Credit Available
A Credit Certificate (for physicians) or Certificate of Participation (for non-physicians) will be provided to individuals seeking credit from the following organizations which accept AMA PRA Category 1 Credit(s)™. Note that participants are advised to contact their certifying body for specific information regarding credit submissions:
· American Academy of Family Physicians (AAFP) (for elective credit)
· American Academy of Nurse Practitioners Certification Board (AANPCB)
· American Academy of Physician Assistants (AAPA)
· American Nurses Credentialing Center (ANCC)
· American Osteopathic Association (AOA) (for Category 2 credit)
· Committee on Accreditation of Continuing Medical Education (Canada)
· European Board for Accreditation in Cardiology (EBAC)
· European CME Credits (ECMEC)
· German Chambers of Physicians
· National Society of Genetic Counselors (for Category 2 credit)
· Oman Medical Specialty Board
· Qatar Council for Healthcare Practitioners
· Royal College of Physicians and Surgeons of Canada (RCPSC)
Content Validation Policy
The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company within the 24 months prior to the disclosure.
The Heart Rhythm Society takes steps to assure its learners and the public that the content of certified activities is accurate and reliable. The following principles are applied to the process of validating CME content. The content is peer-reviewed to ensure the following:
Fair Balance - that content is balanced among various options available for treatment and not biased toward a particular product or manufacturer.
Patient Treatment Recommendations - that patient treatment recommendations contained in the content are evidence-based, are appropriate for the target audience, and that the patient treatment recommendations contribute to overall improvement in patient care.
Scientific Validity - those scientific studies cited in the activity conform to standards accepted by the scientific community.
Learning Objectives - that the educational content supports the learning objectives of the activity, and that the objectives stated for performance-in-practice are actionable and measurable.
Omissions - that no seminal studies, data, or best evidence are missing.